Meiotic recombination: hundreds of deliberate DNA breaks per cell, made by a topoisomerase relative, at sites chosen by a single zinc-finger protein
also called SPO11 · PRDM9 · meiotic DSB · NAHR · crossing over
Every egg and sperm cell is made by deliberately snapping its own chromosomes in hundreds of places so the parents' chromosomes can swap pieces. Where the snaps happen is decided by one protein, and when the swap lines up the wrong repeats, the child is born with a deleted or duplicated chunk of genome.
The same thing, for a scientist
The third and largest-scale example of intended genome breakage, and the one mechanistically closest to KMT2A biology. SPO11 catalyses programmed meiotic double-strand breaks by a topoisomerase-like transesterase mechanism, becoming covalently attached to the DNA end; the protein family is conserved to archaea [E1]. This is the same chemistry as the topoisomerase II cleavage complex that initiates KMT2A breaks (`mechanism-top2-cleavage-at-kmt2a`), which makes SPO11 the cleanest natural precedent for 'a covalent protein-DNA intermediate that is normally resolved and occasionally is not'. Break placement is not intrinsic to SPO11: the zinc-finger methyltransferase PRDM9 specifies hotspots in humans and mice [E2][E3], its allelic variation strongly changes hotspot activity in human sperm [E4], and its binding organises a symmetric nucleosome-depleted region with breaks centred on the motif [E5]. When the ensuing homologous recombination uses the wrong copy of a low-copy repeat, non-allelic homologous recombination produces the recurrent deletions and duplications of genomic disorders [E4][E6].
The transferable idea: breakage is programmed, placement is delegated1 deeper
Meiosis separates two things the KMT2A field usually conflates. The capacity to break is constitutive and enzymatic (SPO11). The choice of where is delegated to a separate, rapidly evolving, chromatin-reading specificity factor (PRDM9) whose alleles change the map 234. The KMT2A breakpoint cluster region likewise does not break at random: it is defined by scaffold attachment regions, topoisomerase II consensus sites and a DNase-hypersensitive site (breakpoint-kmt2a-bcr-architecture), and breakage tracks transcription and 3D folding (mechanism-3d-genome-proximity-partner-choice). The meiotic precedent says that asking 'what is the PRDM9 of the KMT2A BCR' — that is, what chromatin-reading factor delegates placement — is a well-formed question with a known answer shape in another system.
Why PRDM9 is a useful analogy and not a claim
Nobody has proposed a PRDM9-equivalent for KMT2A, and this entry does not. The analogy earns its place because PRDM9's discovery came from exactly the situation the KMT2A field is in: a well-mapped set of recurrent break positions with no known factor specifying them, resolved by asking which rapidly evolving DNA-binding protein correlated with hotspot usage across individuals.
NAHR: the same machinery producing pathological rearrangement
Non-allelic homologous recombination between directly oriented low-copy repeats during meiosis produces recurrent deletions and duplications. Sotos syndrome's common deletion is mediated by directly oriented subunits within inverted low-copy repeats, with a 2.5 kb unequal-crossover hotspot 6; PRDM9 variation influences meiotic instability at a rearrangement underlying genomic disorders 4. Crucially, not all NAHR is meiotic: type 2 NF1 deletions arise by mitotic intrachromosomal recombination and lack the clustered hotspot seen in the meiotic type 1 deletions 7. The distinction matters because a KMT2A translocation is a somatic, mitotic event, and the NF1 comparison is the reminder that mitotic and meiotic rearrangement obey different rules.
- Any attempt to reduce genome breakage pharmacologically runs into the fact that the same covalent-intermediate chemistry is required for meiosis and for normal topoisomerase function; there is no selective 'less breaking' intervention that does not also impair essential processes.
- The NF1 meiotic-versus-mitotic contrast [E7] is a warning against importing meiotic hotspot logic into a somatic translocation problem.
- Is there a PRDM9-like specificity factor that delegates topoisomerase II cleavage to the KMT2A breakpoint cluster region? Nothing has been proposed. A candidate screen would look for chromatin-reading factors whose occupancy across the BCR correlates with etoposide-induced cleavage across cell types.
- SPO11 and TOP2 share the covalent-intermediate chemistry. Meiotic cells resolve SPO11 adducts with MRE11-CtIP endonucleolytic release and TDP2 handles TOP2 adducts. Does TDP2 status modify KMT2A translocation frequency, and has anyone looked for TDP2 variation in infant leukaemia families?
- Meiotic recombination rates differ dramatically between the sexes and with parental age. Is there any parent-of-origin bias in the KMT2A breakpoint or in which chromosome breaks first? Reciprocal-junction sequencing at scale could test this and it has never been reported.
- E1established confidence 5 of 5: Multiple independent lines of evidence; treated as settled in the field.paper
Programmed meiotic double-strand breaks are catalysed by Spo11 via a topoisomerase-like covalent protein-DNA intermediate, in a widely conserved protein family.
Meiosis-specific DNA double-strand breaks are catalyzed by Spo11, a member of a widely conserved protein family · Keeney S, Giroux CN, Kleckner N · Cell 1997What this evidence cannot show
Budding yeast; the mammalian requirement was established subsequently by knockout mice not cited here.
Evidence that argues against this (1)
- 'Catalysed by Spo11' names one subunit of the enzyme. Type IIB topoisomerases are obligate heterodimers of an A subunit (the Spo11-like catalytic subunit) and a B subunit, and the B subunit went unrecognised in meiosis for nearly twenty years: a TopoVIB-Like protein family was identified as an essential, conserved partner required for meiotic double-strand break formation in mouse and plants. The 1997 sequence-homology assignment could not see this, so the covalent-intermediate chemistry is right but the enzyme it belongs to was only half described. It matters for the TOP2 analogy this graph draws, because it means the meiotic machine has a dedicated partner-subunit requirement that TOP2 does not. Robert T et al. 2016
- E2established confidence 5 of 5: Multiple independent lines of evidence; treated as settled in the field.paper
PRDM9 is a major determinant of meiotic recombination hotspot location in humans and mice.
PRDM9 is a major determinant of meiotic recombination hotspots in humans and mice · Baudat F, Buard J, Grey C, Fledel-Alon A, Ober C, Przeworski M, Coop G, de Massy B · Science 2010What this evidence cannot show
Published back-to-back with E3 and should be cited as a pair; PRDM9 explains a large fraction but not all of hotspot placement, and PRDM9 is pseudogenised in some vertebrates that still recombine.
Evidence that argues against this (2)
- The knockout falsifies the strong form of the claim. Prdm9-null mice are proficient at initiating recombination: hotspots are still observed, still at H3K4me3 marks, but relocated to promoters and other sites of PRDM9-independent H3K4 trimethylation that are rarely used in wild-type animals. The authors' conclusion is that PRDM9's role is as much to SEQUESTER the recombination machinery AWAY from gene promoters and functional elements as to create hotspots. 'Determines the positions of hotspots' and 'is required for hotspots' are different statements and only the first survives. Brick K et al. 2012
- A mammalian lineage disproves necessity outright. Canids lack a functional PRDM9, yet a fine-scale linkage-disequilibrium map from 51 free-ranging dogs shows elevated recombination near CpG-rich regions including gene promoters, with little association with spermatocyte H3K4 trimethylation. Recombination is therefore hotspot-structured without PRDM9 at all, by a mechanism the PRDM9 account does not describe. Auton A et al. 2013
- E3established confidence 5 of 5: Multiple independent lines of evidence; treated as settled in the field.paper
Drive against hotspot motifs in primates independently implicates PRDM9 in specifying meiotic recombination hotspots.
Drive against hotspot motifs in primates implicates the PRDM9 gene in meiotic recombination · Myers S, Bowden R, Tumian A, Bontrop RE, Freeman C, MacFie TS, McVean G, Donnelly P · Science 2010What this evidence cannot show
Population-genetic inference rather than direct biochemistry; the causal demonstration comes from E2 and E4 together.
Evidence that argues against this (1)
- Population-genetic drive inference cannot see what direct break mapping sees. High-resolution maps of meiotic double-strand breaks in individual human genomes show that, along with DNA binding by PRDM9, ADDITIONAL factors dictate the efficiency of break formation - so between-individual differences in hotspot usage are not read out from PRDM9 genotype alone. A motif-drive signal in allele-frequency data is consistent with PRDM9 determining hotspots and also with PRDM9 being one of several determinants whose binding sites happen to be the ones under conversion bias. Pratto F et al. 2014
- E4strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper
PRDM9 allelic variation strongly influences human recombination hotspot activity and meiotic instability, including at a rearrangement underlying genomic disorders.
PRDM9 variation strongly influences recombination hot-spot activity and meiotic instability in humans · Berg IL, Neumann R, Lam KW, Sarbajna S, Odenthal-Hesse L, May CA, Jeffreys AJ · Nature Genetics 2010What this evidence cannot show
Sperm-typing in a limited number of donors; effect sizes vary by hotspot and by allele.
Evidence that argues against this (1)
- Generalisability bound that sperm-typing cannot address: these are male gametes. Mapping meiotic double-strand break hotspots in male and female mice found grossly different recombination landscapes arising from up to fifteen-fold differences in hotspot USAGE between the sexes, with most recombination occurring at sex-biased hotspots, partly determined by chromosome structure and by DNA methylation, which is absent in females at the onset of meiosis. An allele's measured hotspot activity in sperm is therefore not that allele's activity in oocytes, and the paper explicitly notes this contradicts past findings in humans. Brick K et al. 2018
- E5strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper
PRDM9 binding organises a symmetric nucleosome-depleted region with meiotic breaks centred on the PRDM9 motif.
PRDM9 binding organizes hotspot nucleosomes and limits Holliday junction migration · Baker CL, Walker M, Kajita S, Petkov PM, Paigen K · Genome Research 2014What this evidence cannot show
Mouse; nucleosome mapping is population-averaged.
Evidence that argues against this (1)
- A symmetric nucleosome-depleted region centred on the motif does not establish that PRDM9 binding suffices to make a break. Humanising the PRDM9 DNA-binding domain in mice showed that altering one Prdm9 allele changes the behaviour of breaks controlled by the OTHER allele at chromosome-wide scales, that these effects track the degree to which a variant binds BOTH homologues at the sites it controls, and that this binding symmetry acts downstream in the recombination process. Population-averaged nucleosome maps at motif-centred sites average over exactly the per-homologue asymmetry that decides which bound sites proceed. Davies B et al. 2016
- E6strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper
A recurrent human deletion syndrome arises by non-allelic homologous recombination between directly oriented low-copy-repeat subunits, with a defined unequal-crossover hotspot.
Sotos syndrome common deletion is mediated by directly oriented subunits within inverted Sos-REP low-copy repeats · Kurotaki N, Stankiewicz P, Wakui K, Niikawa N, Lupski JR · Human Molecular Genetics 2005What this evidence cannot show
One genomic disorder; NAHR is the dominant but not universal mechanism for recurrent genomic rearrangements, and counter-examples exist.
Evidence that argues against this (1)
- PLP1 duplications causing Pelizaeus-Merzbacher disease do not follow the canonical clustered-NAHR model, supporting an alternative mechanism. Lee JA et al. 2006
- E7strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper
Not all non-allelic homologous recombination is meiotic: type 2 NF1 deletions arise by mitotic intrachromosomal recombination and lack the clustered hotspot of the meiotic type 1 deletions.
Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination · Steinmann K, Cooper DN, Kluwe L, Kehrer-Sawatzki H, et al. · American Journal of Human Genetics 2007What this evidence cannot show
Inference of mitotic origin rests on breakpoint distribution and parental-origin data rather than direct observation.
Evidence that argues against this (1)
- The mitotic-origin inference predicts post-zygotic mosaicism, and non-mosaic type-2 NF1 deletions exist. Two patients with non-mosaic (germline) type-2 NF1 deletions have been characterised clinically, with a phenotype matching germline type-1 deletion patients. A germline type-2 deletion cannot have arisen mitotically in the patient, so 'type-2 deletions arise by mitotic intrachromosomal recombination' describes a tendency in the reported series rather than a mechanism that excludes a meiotic or parental-germline route. Vogt J et al. 2011
programmed DNA breakage, mechanism 3 of 5
SPO11 and TOP2 share covalent protein-DNA intermediate chemistry
PRDM9 delegation of hotspot placement is the model for asking what specifies the KMT2A BCR
Counter-evidence (Robert 2016, PMID 26917764): meiotic breaks are made by a two-subunit type IIB topoisomerase-like complex requiring a TopoVIB-Like partner, whereas TOP2 is a homodimeric type IIA enzyme -- the SPO11/TOP2 analogy holds for the covalent intermediate, not for the enzyme or its regulation
Counter-evidence (Brick 2012, PMID 22660327; Auton 2013, PMID 24348265): Prdm9-null mice still initiate recombination, relocating hotspots to promoters, and canids lack functional PRDM9 entirely -- PRDM9 positions hotspots and sequesters the machinery away from functional elements rather than being required for them
Counter-evidence (Davies 2016, PMID 26840484): humanising the PRDM9 zinc-finger domain repositions hotspots genome-wide and restores hybrid fertility, and one allele alters breaks controlled by the other -- a single canonical accession represents one allele of a hypervariable minisatellite, not the protein's functional determinant